Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Heptares' StaR platform offers breakthrough solution to challenge associated with antibodies therapeutics

Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, achieved the first research milestone in its antibody therapeutics alliance with MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX), announced in February 2013.

10 Oct 2013

Lundbeck, Otsuka to continue development of Lu AE58054 compound for Alzheimer's disease

H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. announced today the continuation of the development program of Lu AE58054 for the treatment of Alzheimer's disease, initiating the first out of four phase III clinical trials with the compound.

10 Oct 2013

Research findings leave considerable room for improvement in stroke treatment

Stroke treatments and prevention to improve quality of life for people who experience a stroke is poorer than researchers hoped, with stroke still taking nearly three out of five quality years off a person's life, according to a new study published in the October 9, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology.

10 Oct 2013

TSRI scientists identify set of compounds to treat multiple sclerosis in new way

Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune system, the compounds boost a population of progenitor cells that can in turn repair MS-damaged nerve fibers.

10 Oct 2013

Studies suggest infusion of blood vessel cells may contribute to organ regeneration in future

Damaged or diseased organs may someday be healed with an injection of blood vessel cells, eliminating the need for donated organs and transplants, according to scientists at Weill Cornell Medical College.

9 Oct 2013

Study discovers biomarker that helps doctors to accurately diagnose Parkinson's at earlier stage

Although Parkinson's disease is the second most prevalent neurodegenerative disorder in the U.S., there are no standard clinical tests available to identify this widespread condition.

8 Oct 2013

Researchers identify protein that triggers inflammation in patients with hemorrhage, sepsis

Investigators at The Feinstein Institute for Medical Research have discovered a protein in the human body that can trigger and mediate inflammation in patients suffering from hemorrhage and sepsis. The findings were published in the online version of Nature Medicine on October 6, 2013.

7 Oct 2013

Study shows precision medicine provides better treatment options for mentally ill person

A multidisciplinary team led by a geneticist and psychiatrist from Cold Spring Harbor Laboratory's (CSHL) Stanley Institute for Cognitive Genomics today publish a paper providing a glimpse of both the tremendous power and the current limitations of what is sometimes called "precision medicine."

5 Oct 2013

Depressed people may have triple times risk of developing Parkinson's

People who are depressed may have triple the risk of developing Parkinson's disease, according to a study published in the October 2, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.

3 Oct 2013

Adamas Pharmaceuticals reports positive results from ADS-5102 Phase 2/3 EASED clinical trial

Adamas Pharmaceuticals, Inc. presented positive results today from the Phase 2/3 EASED clinical trial of ADS-5102 at the World Parkinson's Congress. ADS-5102 is Adamas' proprietary long-acting capsule formulation of amantadine HCl in development for the treatment of levodopa-induced dyskinesia in Parkinson's disease patients.

2 Oct 2013

Scientists move closer to growing therapeutic brain cells in laboratory

Bethesda, MD-A group of really brainy scientists have moved closer to growing "therapeutic" brain cells in the laboratory that can be re-integrated back into patients' brains to treat a wide range of neurological conditions.

1 Oct 2013

Pitt scientists open door to potential research into cures for Parkinson's disease

A mix of serendipity and dogged laboratory work allowed a diverse team of University of Pittsburgh scientists to report in the Oct. 1 issue of Nature Cell Biology that they had solved the mystery of a basic biological function essential to cellular health.

1 Oct 2013

Epigenetic changes appear to be candidates as early stage biomarkers for Parkinson

Parkinson disease, a neurodegenerative disorder in which both genetic and environmental factors play important roles, has been associated with epigenetic changes (those molecular modifications that alter the behavior of genes without changing the DNA sequence).

26 Sep 2013

Research suggests omega-3 fatty acids may not benefit thinking skills

Contrary to earlier studies, new research suggests that omega-3 fatty acids may not benefit thinking skills. The study is published in the September 25, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology. Omega-3s are found in fatty fish such as salmon and in nuts.

26 Sep 2013

Small alteration in a brain gene contributes to risk for anxiety, depression and memory loss

Researchers at Weill Cornell Medical College have discovered why a tiny alteration in a brain gene, found in 20 percent of the population, contributes to the risk for anxiety, depression and memory loss.

20 Sep 2013

LCT successfully implants first patient with potential Parkinson's disease treatment

Living Cell Technologies Limited today announced that the first patient has been successfully implanted in the Phase I clinical trial of the regenerative cell therapy NTCELL – a potential treatment for Parkinson's disease.

20 Sep 2013

Google Eyes Wider Healthcare Footprint With Tech-Focused Calico

...

19 Sep 2013

Blood lipid marker may help predict risk for Parkinson's disease

A genetic mutation, known as GBA, that leads to early onset of Parkinson's disease and severe cognitive impairment (in about 4 to 7 percent of all patients with the disease) also alters how specific lipids, ceramides and glucosylceramides are metabolized. Mayo Clinic researchers have found that Parkinson's patients who do not carry the genetic mutation also have higher levels of these lipids in the blood. Further, those who had Parkinson's and high blood levels were also more likely to have cognitive impairment and dementia.

19 Sep 2013

New evidence suggests that taking vitamin B supplements may help reduce risk of stroke

New evidence suggests that taking vitamin B supplements may help reduce the risk of stroke. The research appears in the September 18, 2013, online issue of Neurology®, the medical journal of the American Academy of Neurology.

19 Sep 2013

Nonmotor symptoms contribute to early Parkinson’s subtypes

Researchers have characterized four distinct subgroups of patients with early Parkinson’s disease, distinguished by both motor and nonmotor symptoms.

18 Sep 2013

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

Heptares' StaR platform offers breakthrough solution to challenge associated with antibodies therapeutics

Lundbeck, Otsuka to continue development of Lu AE58054 compound for Alzheimer's disease

Research findings leave considerable room for improvement in stroke treatment

TSRI scientists identify set of compounds to treat multiple sclerosis in new way

Studies suggest infusion of blood vessel cells may contribute to organ regeneration in future

Study discovers biomarker that helps doctors to accurately diagnose Parkinson's at earlier stage

Researchers identify protein that triggers inflammation in patients with hemorrhage, sepsis

Study shows precision medicine provides better treatment options for mentally ill person

Depressed people may have triple times risk of developing Parkinson's

Adamas Pharmaceuticals reports positive results from ADS-5102 Phase 2/3 EASED clinical trial

Scientists move closer to growing therapeutic brain cells in laboratory

Pitt scientists open door to potential research into cures for Parkinson's disease

Epigenetic changes appear to be candidates as early stage biomarkers for Parkinson

Research suggests omega-3 fatty acids may not benefit thinking skills

Small alteration in a brain gene contributes to risk for anxiety, depression and memory loss

LCT successfully implants first patient with potential Parkinson's disease treatment

Google Eyes Wider Healthcare Footprint With Tech-Focused Calico

Blood lipid marker may help predict risk for Parkinson's disease

New evidence suggests that taking vitamin B supplements may help reduce risk of stroke

Nonmotor symptoms contribute to early Parkinson’s subtypes

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in